Who makes Benvitimod Cream?

Benvitimod Cream is developed by Peking University People's Hospital.

What development phase is Benvitimod Cream in?

Benvitimod Cream is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Benvitimod Cream

Peking University People's Hospital · FDA-approved active Small molecule Quality 0/100

At a glance

Generic name	Benvitimod Cream
Sponsor	Peking University People's Hospital
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Phase III Clinical Study of Benvitimod Cream in the Treatment of Mild to Moderate Atopic Dermatitis (PHASE3)
Efficacy and Safety of Benvitimod Cream in the Retreatment of Mild to Moderate Psoriasis (NA)
Phase IV Clinical Study of Benvitimod Cream in the Treatment of Mild to Moderate Psoriasis in Adults (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Benvitimod Cream CI brief — competitive landscape report
Benvitimod Cream updates RSS · CI watch RSS
Peking University People's Hospital portfolio CI